Invivyd Inc (IVVD)
Invivyd Reports Third Quarter 2025 Financial Results and Recent Business Highlights
Avenue Therapeutics Inc (ATXI)
Avenue Therapeutics Announces Acquisition of Subsidiary Baergic Bio by Axsome Therapeutics
Ligand Pharmaceuticals Incorporated (LGND)
Ligand Reports Third Quarter 2025 Financial Results and Raises Guidance
Achieve Life Sciences Inc. (ACHV)
Achieve Life Sciences Reports Third Quarter 2025 Financial Results; Provides Updates on Cytisinicline Program
Axsome Therapeutics Inc (AXSM)
Axsome Therapeutics Acquires Subtype Selective GABA-A Receptor Positive Allosteric Modulator AZD7325 for the Treatment of Epilepsy
Neumora Therapeutics Inc. (NMRA)
Neumora Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
Immunocore Holdings plc (IMCR)
Immunocore reports third quarter financial results and provides a business update
Medicenna Therapeutics Corp (MDNAF)
Medicenna and Fondazione Melanoma Onlus Collaborate to Advance MDNA11 Before First-Line Therapy in a Randomized Neoadjuvant Combination Trial, “NEO-CYT”, in High-Risk, Surgically Resectable Stage III Melanoma
Fortress Biotech Inc. (FBIOP)
Avenue Therapeutics Announces Acquisition of Subsidiary Baergic Bio by Axsome Therapeutics
American Shared Hospital Srvcs (AMS)
American Shared Hospital Services Announces Third Quarter Financial Results Conference Call